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Abstract
The Ly49E NK receptor is a unique inhibitory receptor, presenting with a high degree of conservation among mouse strains
and expression on both NK cells and intraepithelial-localised T cells. Amongst intraepithelial-localised T cells, the Ly49E
receptor is abundantly expressed on CD8aa-expressing innate-like intestinal intraepithelial lymphocytes (iIELs), which
contribute to front-line defense at the mucosal barrier. Inflammatory bowel diseases (IBDs), encompassing Crohn’s disease
and ulcerative colitis, have previously been suggested to have an autoreactive origin and to evolve from a dysbalance
between regulatory and effector functions in the intestinal immune system. Here, we made use of Ly49E-deficient mice to
characterize the role of Ly49E receptor expression on CD8aa-expressing iIELs in the development and progression of IBD.
For this purpose we used the dextran sodium sulphate (DSS)- and trinitrobenzenesulfonic-acid (TNBS)-induced colitis
models, and the TNFDARE ileitis model. We show that Ly49E is expressed on a high proportion of CD8aa-positive iIELs, with
higher expression in the colon as compared to the small intestine. However, Ly49E expression on small intestinal and
colonic iIELs does not influence the development or progression of inflammatory bowel diseases.
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Introduction
Inflammatory bowel diseases (IBDs), encompassing Crohn’s
disease and ulcerative colitis, are chronic and relapsing disorders
of the gastrointestinal tract [1]. Although the etiology of IBD is
incompletely understood, inflammatory bowel disorders are
believed to present in genetically predisposed individuals exposed
to undefined microbial and environmental triggers. In this, IBD
pathogenesis has been linked to deregulation of the fine
homeostatic balance that exists between the mucosal immune
system and commensal microbiota [2–5]. With the highest
worldwide prevalence, European figures show an estimated 1 in
200 people affected by ulcerative colitis, and 1 in 300 affected by
Crohn’s disease [6,7]. Current IBD treatment options include the
administration of anti-inflammatory drugs, immunosuppressives
and immunobiological agents [8,9]. For unresponsive patients,
surgical intervention may provide a temporary relieve from
symptoms. However, specificity is lacking in these modes of
treatment, and none are capable of inducing complete remission
[8,10]. Therefore, additional research is required to further
elucidate IBD mechanisms and facilitate the development of
specific and effective new therapies.
Intestinal intraepithelial lymphocytes (iIELs) are resident
lymphocytes of the intestinal epithelium, and constitute one of
the largest lymphocyte populations of the body [11]. In mice, five
main subpopulations of iIELs have been identified: CD4, CD8ab
and CD8aa T cell receptor (TCR)ab iIELs, and CD4/CD8
double-negative (DN) and CD8aa TCRcd iIELs. TCRab CD4
and TCRab CD8ab iIELs have been described as being ‘induced’
iIELs, whereas TCRab CD8aa, TCRcd DN and TCRcd CD8aa
iIELs are also referred to as ‘natural’ iIELs [12]. More recently,
Mucida et al. [13] have also described the existence of a sixth iIEL
subpopulation, the TCRab CD4 CD8aa double-positive (DP)
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iIELs. Numerous reports indicate an important role for iIELs in
maintaining mucosal homeostasis. In this context, iIELs have been
implicated in the recognition of stress signals [14], repair of the
intestinal epithelium [15–17], may function as memory cells [18],
show cytotoxic activity [19,20], and have autoreactive properties
[21,22]. In addition, iIELs are characterized by an ‘activated yet
resting’ phenotype [20], suggesting the capacity to respond rapidly
to in vivo stimuli and the need for tight regulation of iIEL effector
function. However, exact mechanisms involved in iIEL regulatory
and effector functions remain largely unknown.
Unique to iIELs is the large number of cells expressing the
CD8aa homodimer [23]. Recently, our group showed that
Ly49E, an inhibitory receptor, is abundantly expressed on
CD8aa-expressing iIELs of the small intestine [24]. We demon-
strated that iIELs expressing inhibitory Ly49 receptors, including
Ly49E, are hyporesponsive to TCR-mediated stimulation [24].
Importantly, in vitro TCR-triggering results in upregulation of
Ly49E receptor expression on iIELs [25]. Furthermore, we were
able to show that the Ly49E receptor can be triggered by the non-
MHC-related protein urokinase plasminogen activator (uPA).
Interestingly, several studies have indicated a role for uPA in IBD,
with increased levels of tissue uPA present in Crohn’s disease and
ulcerative colitis patients as compared to healthy controls [26,27].
Thus, we hypothesized that Ly49E expression on CD8aa-
expressing iIELs constitutes a novel mechanism through which
iIEL function can be regulated. To test our hypothesis in vivo, we
have generated Ly49E knockout (KO) mice on a C57BL/6
background. Here, we investigated a role for Ly49E expression on
iIELs in the context of IBD development and progression, making
use of the dextran sodium sulphate (DSS)- and trinitrobenzene-
sulfonic-acid (TNBS)- induced colitis models, and the TNFDARE
ileitis model. Our results indicate that Ly49E expression on both
small intestinal and colonic CD8aa-expressing iIELs is abundant.
However, abrogation of Ly49E expression on iIELs of the small
intestine and colon does not influence development or progression
of IBD.
Materials and Methods
Mice
The generation of Ly49E KO mice on a C57BL/6 background
was outsourced to Ozgene (Bentley DC, WA, Australia), and the
targeting strategy is explained elsewhere [28]. Heterozygous
Ly49EWT/KO mice were interbred to obtain homozygous
Ly49EWT/WT and Ly49EKO/KO mice. TNFDARE/WT mice were
a kind gift from Dr. G. Kollias (Institute for Immunology,
Biomedical Sciences Research Center ‘‘Alexander Fleming,’’
Attica, Greece). Heterozygous TNFDARE/WT (Ly49EWT/WT) mice
were bred to homozygous (TNFWT/WT) Ly49EKO/KO mice in
order to obtain TNFDARE/WT Ly49EWT/KO offspring. Male
TNFDARE/WT Ly49EWT/KO and female TNFWT/WT Ly49EWT/
KO offspring were bred to obtain homozygous TNFDARE/WT
Ly49EWT/WT and TNFDARE/WT Ly49EKO/KO mice. All mice
were housed and bred in our animal facility, and all animal
experimentation was performed after approval and according to
the guidelines of the Ethical Committee for Experimental Animals
at the Faculty of Medicine and Health Sciences of Ghent
University (Ghent, Belgium).
Genotyping of mice
Genomic DNA was extracted from tail tissue samples, according
to the REDExtract-N-Amp Tissue PCR Kit (Sigma-Aldrich, St.
Louis, MO, USA). PCR amplification of genomic DNA for the
TNF locus was carried out with the following primers: forward-
59CCTTCCTCACAGAGCCAGC-39 and reverse-59-AATTAC-
GGTTAGGCTCCTGTTTCC-39. Following agarose gel electro-
phoresis, TNFDARE and wild-type (WT) alleles yield bands of 626
and 560 bp, respectively. PCR amplification of genomic DNA for
the Ly49E locus was carried out making use of the following
primers: for the WT allele, forward-59-TCGCTTGGAATCTT-
CTGTTTC-39 and reverse-59TCCTCACCTGGACTGCAAT-
C-39; for the KO allele, forward-59GGAATAATTGCTGTTAC-
CATTAG in combination with reverse-59TCCTCACCTGGA-
CTGCAATC-39. Ly49E WT and KO alleles yield bands of 1070
and 1200 bp, respectively.
DSS-induced colitis
Colitis was induced in 8-week old mice by administering 4%
(w/v) DSS (molecular weight 36,000–50,000, MP Biomedicals,
Cleveland, USA) in drinking water and allowing mice to drink ad
libidum for 7 days. Following 7 days of DSS treatment, drinking
water containing DSS was replaced by normal drinking water and
mice were allowed to recover. Control mice received normal
drinking water only.
Assessment of the disease activity index in DSS-induced
colitis
The disease activity index (DAI) was scored as follows: weight
loss, score 0–5 (0: ,1% change in weight, 1: 1–5% change in
weight, 2: 6–10% change in weight, 3: 11–15% change in weight,
4: 16–20% change in weight, 5: .20% change in weight),
appearance, score 0–2 (0: healthy appearance, 1: unkempt fur
coat, 2: arched back), fecal consistency, score 0–2 (0: normal, 1:
soft pellets, 2: diarrhea) and fecal occult blood, score 0–5, using the
ColoScreen Hemoccult test (Helena Laboratories, Texas, USA) (0:
Hemoccult negative, 1: Hemoccult +, 2: Hemoccult ++, 3:
Hemoccult +++, 4: Hemoccult ++++ or marked bleeding, 5:
visible indications of rectal bleeding and prolapse). An individual
score was assigned to each mouse on a daily basis.
TNBS-induced colitis
Prior to administration of TNBS, mice were sedated through
intraperitoneal injection with a mixture (2.5 ml/g body weight) of
ketamine (50 mg/ml: 4 volumes) and xylazine (2%: 1 volume). For
induction of TNBS-induced colitis, mice were rectally adminis-
tered a solution (0.1 ml/mouse) of 2.5% (w/v) TNBS (Sigma-
Aldrich) in 50% ethanol solution. Control mice received a solution
(0.1 ml/mouse) of PBS in 50% ethanol solution. Mice were kept in
a vertical position for 1 min to prevent rectal leakage.
iIEL isolation
iIELs from 8-to-14 week old mice were isolated as follows.
Briefly, intestines were removed and cleaned of mesenteric fat.
Peyer’s patches were excised, and intestines were rinsed with
DPBS to clear intestines of fecal content. Subsequently, intestines
were opened longitudinally, cut into 0.5-cm pieces, and transferred
to a 50-ml conical tube. Intestines were incubated twice for
20 minutes at 37uC in Ca/Mg-free Hank’s Balanced Sodium
Solution (HBSS; Invitrogen, Carlstad, CA, USA) containing 5%
FCS, 1 mM ethylenediaminetetraacetic acid (EDTA; Invitrogen)
and 1 mM dithiotreitol (Sigma-Aldrich) at slow rotation. Cell
suspensions were passed through a 40-mm cell strainer (Falcon,
Becton Dickinson, Franklin Lakes, NJ, USA) and pelleted by
centrifugation at 480 g. Pellets were resuspended in 44% Percoll
(GE Healthcare, Buckinghamshire, UK) on an underlay of 67%
Percoll, and centrifugated for 20uC at 2000 g. iIELs were collected
from the 44%/67% Percoll interface, washed twice with
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phosphate buffered saline (PBS) for 5 minutes at 840 g, and
resuspended in RPMI 1640 medium supplemented with 10%
FCS, 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM
glutamine, 1 mM sodium pyruvate, 100 mM non-essential amino
acids (all Invitrogen) and 50 mM 2-mercaptoethanol (Sigma-
Aldrich).
Antibodies
mAbs used for staining of iIELs were as follows: anti-TCRb
(APC/Cy7-conjugated, clone H57.597), anti-CD4 (peridinin
chlorophyll protein/Cy5.5-conjugated, clone GK1.5), anti-CD8b
(peridinin chlorophyll protein/Cy5.5-conjugated, clone
YTS156.7.7), all from BioLegend, San Diego, CA, USA. Anti-
TCRd (PE- or FITC-conjugated, clone GL3), anti-Ly49D (FITC-
conjugated, clone 4E5), anti-Ly49C/I (PE-conjugated, clone 5E6),
anti-NKG2D (PE-conjugated, clone CX5), anti-CD69 (biotin-
conjugated, clone H1.2F3), were obtained from Becton Dickinson,
Franklin Lakes, NJ, USA. Anti-CD8a (PE/Cy7-conjugated, clone
53–6.7) from eBioscience, San Diego, CA, USA. Anti-Ly49G2-
producing hybridoma (clone 4D11) was from ATCC and antibody
was biotin- or FITC-conjugated in-house. Anti-Ly49A (biotin-
conjugated, clone JR9-318; kindly provided by Dr J. Roland
(Paris, France)), anti-Ly49E/C (biotin- or FITC-conjugated, clone
4D12, made and labeled in-house) [29] and anti-Ly49E/F (FITC-
conjugated, clone CM4; kindly provided by Dr C. G. Brooks
(Newcastle on Tyne, UK) [30]. mAb 4D12 (Ly49C/E) in
combination with mAb CM4 (Ly49E/F) were used to identify
Ly49C-expressing cells (CM42/4D12+), Ly49E-expressing cells
(CM4+/4D12+) and Ly49F-expressing cells (CM4+/4D122). In B6
(H-2b) mice, mAb 5E6 stains Ly49I, whereas Ly49C is very hard
to detect [31]. Anti-Ly49H (biotin-conjugated, clone 3D10; kindly
provided by Dr. W. Yokoyama, St.Louis, MO, USA)) and anti-
NKG2A/C/E (FITC-conjugated, clone 3S9, generated and
labeled in-house) [29].
Prior to staining, cells were blocked with anti-FccRII/III
(unconjugated, clone 2.4G2, kindly provided by Dr J. Unkeless,
Mount Sinai School of Medicine, New York, USA). Propidium
iodide was used to discriminate live and dead cells. Flow cytometry
was performed using a BD LSRII flow cytometer, and samples
were analysed with FACSDiva Version 6.1.2 software (BD
Biosciences).
Histology
For histological analysis, tissue sections of the distal ileum and
distal colon were fixed in 4% formaldehyde solution (VWR,
Radnor, Pennsylvania, USA) and embedded in paraffin. 5 mm
paraffin-embedded sections were stained with hematoxylin and
eosin (Sigma-Aldrich). Intestinal inflammation was scored blindly
by two independent observers using a validated scoring system, as
previously described [32].
Statistics
Statistical analysis was carried out using PASW Statistics 22
Software (SPSS, Chicago, IL, USA). Data was analysed using the
non-parametric two-tailed Mann-Whitney U-test or ANOVA, as
indicated. A P value #0.05 was considered statistically significant.
Results
Ly49E KO mice have normal iIEL population frequencies
and NK receptor expression
As the function of Ly49E expression on iIELs of the intestine is
currently unknown, we initially sought to clarify whether Ly49E
expression on iIELs affects differentiation of intestinal iIELs. In
this respect, we found that total numbers of iIELs present in the
small intestine of Ly49E WT and Ly49E KO mice
(8.68610662.50 vs. 6.60610661.15 iIELs, respectively) and
colon of Ly49E WT and Ly49E KO mice (0.32610660.10 vs.
0.46610660.20) were similar. Furthermore, iIEL subpopulation
frequencies, and the total number of cells in each iIEL
subpopulation, did not differ significantly between Ly49E WT
and Ly49E KO mice (Fig. 1A and 1B, and data not shown). We
and others have previously shown that several NK receptors are
expressed on the surface of small intestinal iIELs. In particular,
Ly49E is expressed on a higher proportion of CD8aa-positive
iIELs than other Ly49 receptors [24,33]. Here, we show that
several NK receptors are also expressed on the surface of colonic
CD8aa-positive iIELs. As for small intestinal iIEL expression, a
high proportion of colonic iIELs express the Ly49E receptor.
Surprisingly, the frequency of Ly49E-expressing colonic TCRcd
CD8aa-positive iIELs exceeds the frequency of Ly49E-expressing
TCRcd CD8aa-positive iIELs in the small intestine, whereas we
found the proportion of Ly49E-expressing TCRab CD8aa-
positive iIELs in the small intestine and colon to be comparable.
As expected, Ly49E expression is absent on iIELs of Ly49E KO
mice. Small intestinal and colonic iIEL NK receptor expression
was unchanged between Ly49E WT and Ly49E KO mice
(Fig. 2A and 2B). Furthermore, co-expression of Ly49 receptors
on the iIEL surface was unaltered between Ly49E WT and Ly49E
KO mice (Fig. 2C and 2D). Ly49E expression on CD8aa-negative
iIELs was low or absent (data not shown).
Ly49E expression on CD8aa-expressing iIELs of the colon
does not influence DSS-induced colitis
To study a possible role for Ly49E expression on colonic
CD8aa-expressing iIELs in the context of colitis, we performed
DSS-induced colitis with Ly49E WT and Ly49E KO mice. DSS
was administered to mice in drinking water for a period of 7 days,
after which DSS-containing water was replaced by normal
drinking water. Mice were analysed on a daily basis for a total
of 11 days. As shown in Fig. 3A, we observed no difference in
relative weight loss between Ly49E WT and Ly49E KO mice.
Additionally, we analysed the DAI on a daily basis. Here, we
observed no significant difference between the DAI of Ly49E WT
and Ly49E KO mice between days 0–11 (p$0.35; Mann-Whitney
test) (Fig. 3B). This was corroborated by histological scores of
distal colon formalin fixed paraffin-embedded (FFPE-) sections
obtained from Ly49E WT and Ly49E KO mice at days 7, 9 and
11 following colitis induction, which indicate a similar degree of
inflammation for Ly49E WT and Ly49E KO mice (Fig. 3C and
3D). Studying a role for Ly49E expression on colonic iIELs, we
analysed iIEL subpopulation frequencies and iIEL NK receptor
and activation marker expression at days 0, 7 and 11 of DSS-
induced colitis. As illustrated, iIEL subpopulation frequencies and
iIEL NK receptor and activation marker expression were
unchanged on days 7 and 11 as compared to untreated mice on
day 0, and were unchanged between Ly49E WT and Ly49E KO
mice (Fig. 4A, 4B and 4C). Hall et al. [34] recently reported an
increased frequency of NKG2D expression on NK cells in DSS-
induced colitis. As iIELs have a number of innate-like properties
and are crucial to front-line defense of the intestinal mucosal
barrier [12,18–22], we examined whether iIELs upregulate
NKG2D expression upon DSS-induced colitis. Using littermate
DSS-treated and control mice, we observe a trend towards
upregulation of NKG2D expression on TCRab CD8aa-positive
iIELs and TCRcd CD8aa-positive iIELs in DSS-induced colitis,
but this was not significant (p$0.083; Mann-Whitney test).
NKG2D expression between Ly49E WT and Ly49E KO
Ly49E Expression on iIELs in Inflammatory Bowel Diseases
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DSS-treated mice was comparable (Fig. 5A and 5B). Thus, Ly49E
expression on colonic CD8aa-expressing iIELs does not appear to
influence DSS-induced colitis development or progression.
Ly49E expression on CD8aa-expressing iIELs of the colon
does not affect TNBS-induced colitis
A second frequently used model in the study of mucosal
immunity is that of TNBS-induced colitis. Here, we show that
colitis induction in both Ly49E WT and Ly49E KO occurred
rapidly, with the first cases of mortality noted at 5 and 3 days post-
treatment for Ly49E WT and Ly49E KO mice, respectively.
Seven days following TNBS-colitis induction, 50% of mice had
died in both Ly49E WT and Ly49E KO-treated groups, and the
decision was made to terminate treatment and euthanize the
remaining mice (Fig. 6A). Maximum weight loss for Ly49E WT
and Ly49E KO mice occurred at day 5 and day 3, respectively,
following the start of treatment, and weight loss differences
between Ly49E WT and KO mice were not significant (Mann-
Whitney test) on all days analysed (Fig. 6B). FFPE-sections of the
distal colon of Ly49E WT and Ly49E KO mice were obtained
72 h following induction of colitis, and scored as described. As
shown in Fig. 6C and 6D, colonic inflammation in the colon of
both Ly49E WT and Ly49E KO treated mice was comparable in
severity. A role for Ly49E expression on colonic CD8aa-
expressing iIELs was investigated by comparing iIEL numbers,
iIEL subpopulation frequencies and iIEL NK receptor expression
of Ly49E WT and Ly49E KO-treated mice 72 h after treatment
start. Here, we found the total number of iIELs, iIEL subpopu-
lation frequencies and iIEL NK receptor expression to be
unchanged between Ly49E WT and Ly49E KO mice 72 h after
treatment initiation as compared to healthy control mice (data not
shown). Therefore, we conclude that Ly49E expression on colonic
CD8aa-expressing iIELs does not alter TNBS-induced colitis
development or progression.
TNFDARE/WT Ly49EWT/WT and TNFDARE/WT Ly49EKO/KO mice
display similar ileitis development and progression
To study the role of Ly49E expression on small intestinal iIELs
in the context of ileitis development and progression, we employed
the TNFDARE model of ileitis. Harbouring a deletion of the TNF
39 AU-rich elements, TNFDARE/WT mice develop spontaneous
ileitis that highly resembles human Crohn’s disease [35,36]. Here,
we bred Ly49E WT and Ly49E KO mice to heterozygous
TNFDARE/WT mice in two rounds, generating TNFDARE/WT
Ly49EWT/WT and TNFDARE/WT Ly49EKO/KO offspring. Moni-
toring weight progression of TNFDARE/WT Ly49EWT/WT and
TNFDARE/WT Ly49EKO/KO mice, and their littermate controls,
we noted decreased weights for TNFDARE/WT mice as compared
to TNFWT/WT mice, as expected. Furthermore, we observed no
significant difference in weight progression of TNF DARE/WT
Ly49EWT/WT versus TNFDARE/WT Ly49EKO/KO mice between 5
and 14 weeks of age (Fig. 7A). Subsequently, we analysed iIEL
numbers, subpopulation frequencies, NK receptor and activation
marker expression in TNFDARE/WT Ly49EWT/WT and TNFDARE/
WT Ly49EKO/KO mice and their littermate controls at the age of
10 weeks, by which time ileitis is fully developed. Total numbers of
iIELs isolated from the small intestine of TNFDARE/WT Ly49EWT/
WT and TNFDARE/WT Ly49EKO/KO mice were similar
(8.57610662.73 vs. 9.57610663.39 iIELs, respectively). Studying
iIEL subpopulation frequencies, we noted a significant increase in
TCRab CD4 iIELs (p#0.001; ANOVA), and a significant
decrease in TCRab CD8aa iIELs (p#0.001; ANOVA), in the
intestines of TNFDARE/WT Ly49EWT/WT and TNFDARE/WT
Ly49EKO/KO mice as compared to their littermate controls.
However, no differences were observed in iIEL subpopulation
frequencies between TNFDARE/WT Ly49EWT/WT and TNFDARE/
WT Ly49EKO/KO mice (Fig. 7B). Similarly, we noted no significant
differences in the NK receptor expression of iIELs from
TNFDARE/WT Ly49EWT/WT and TNFDARE/WT Ly49EKO/KO
mice (data not shown). To confirm that iIELs were activated in
this TNFDARE ileitis model, we stained iIELs for expression of the
activation marker CD69. Small intestinal iIELs from TNFDARE/
Figure 1. iIEL subpopulation frequencies in the small intestine and colon of Ly49E WT versus Ly49E KO mice. A) iIEL subpopulation
frequencies in the small intestine of Ly49E WT versus Ly49E KO mice. TCRab and TCRcd iIEL population frequencies are shown as a percentage of the
total iIELs present in the small intestine and colon of Ly49E WT versus Ly49E KO mice. TCRab CD4, TCRab CD8ab and TCRab CD8aa iIEL
subpopulation frequencies are shown as a percentage of the total TCRab iIELs. TCRcd DN and TCRcd CD8aa iIEL subpopulation frequencies are
shown as a percentage of the total TCRcd iIELs. B) iIEL subpopulation frequencies in the colon of Ly49E WT versus Ly49E KO mice. Representation of
iIEL subpopulation frequencies is the same as for Fig. 1A. iIEL subpopulation frequencies are shown as mean values (n = 5, small intestine; n = 5, colon,
where each value is derived from a pool of 3 mice).
doi:10.1371/journal.pone.0110015.g001
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WT Ly49EWT/WT and TNFDARE/WT Ly49EKO/KO mice expressed
significantly higher CD69 levels as compared to their littermate
controls for both TCRab CD8aa and TCRcd CD8aa iIELs (p#
0.001; ANOVA). However, CD69 expression levels were compa-
rable between TNFDARE/WT Ly49EWT/WT and TNFDARE/WT
Ly49EKO/KO mice, and between control Ly49E WT and Ly49E
KO mice (Fig. 7C). All experiments were repeated with mice at 14
weeks of age, and similar results were obtained (data not shown).
Together, this data suggests that Ly49E expression on small
intestinal iIELs does not affect ileitis development or progression.
Discussion
In this paper we show that the Ly49E NK receptor is
abundantly expressed on CD8aa-expressing iIELs of the small
intestine as well as the colon. Herein, the frequency of Ly49E-
expressing colonic CD8aa-positive iIELs is greater than the
frequency of Ly49E-expressing small intestinal CD8aa-positive
iIELs. Because of the relatively high Ly49E expression on iIELs,
we initially sought to investigate whether Ly49E expression
influences iIEL differentiation or the iIEL NK receptor expression
profile. In this regard, we show that Ly49E KO mice have
unchanged iIEL subpopulation frequencies and a similar NK
receptor expression profile to Ly49E WT. Thus, we show that
Ly49E expression on iIELs does not affect the development or NK
receptor expression profile of basal resting iIELs.
Upon iIEL activation, a number of reports have demonstrated a
function for these cells in regulating the development and
progression of ulcerative colitis. Recently, Meehan et al. [37]
illustrated that interaction of CD100 on cd-iIELs with plexin B2
on epithelial cells is required for keratinocyte-growth factor (KGF-
1)-mediated epithelial repair following DSS-induced colitis. A role
Figure 2. iIEL NK receptor expression in the small intestine and colon of Ly49E WT versus Ly49E KOmice. A) NK receptor expression on
TCRab CD8aa iIELs and TCRcd CD8aa iIELs in the small intestine of Ly49E WT versus Ly49E KO mice. B) NK receptor expression on TCRab CD8aa iIELs
and TCRcd CD8aa iIELs in the colon of Ly49E WT versus Ly49E KO mice. C) Co-expression of Ly49 receptors on the iIEL surface of TCRab CD8aa iIELs
and TCRcd CD8aa iIELs in the small intestine of Ly49E WT versus Ly49E KO mice. Numbers indicate the percentage of cells expressing or co-
expressing the indicated Ly49 receptors, and are representative of 3 mice. D) Co-expression of Ly49 receptors on the iIEL surface of TCRab CD8aa
iIELs and TCRcd CD8aa iIELs in the colon of Ly49E WT versus Ly49E KO mice. Numbers indicate the percentage of cells expressing or co-expressing
the specific Ly49 receptors, and are representative of 3 mice. iIEL NK receptor expression is presented as the mean 6SD (n = 5, small intestine; n = 5,
colon, where each value represents the mean of a pool of 3 mice).
doi:10.1371/journal.pone.0110015.g002
Figure 3. Clinical symptoms of DSS-induced colitis in Ly49E WT versus Ly49E KO mice. Colitis was induced in Ly49E WT and Ly49E KO
mice by administration of DSS in drinking water for 7 days. Thereafter, mice received normal drinking water. Ly49E WT and Ly49E KO mice were
scored and compared at the indicated days. A) Relative weight loss (mean 6SD; n = 71). The reference weight was taken as the weight on day 0, at
the start of the experiment. B) Disease activity index (mean 6SD; n = 71). C) Colon histological score (mean 6SD; n= 6 on day 7, n = 5 on day 9 and
n= 10 on day 11). D) Representative hematoxylin/eosin-stained paraffin sections of the distal colon.
doi:10.1371/journal.pone.0110015.g003
Ly49E Expression on iIELs in Inflammatory Bowel Diseases
PLOS ONE | www.plosone.org 6 October 2014 | Volume 9 | Issue 10 | e110015
Figure 4. iIEL NK receptor expression upon DSS-induced colitis in Ly49E WT versus Ly49E KO mice. A) Colon iIEL subpopulation
frequencies (mean 6SD; n = 5 on day 0, n = 3 on day 7 and n= 4 on day 11, where each value is derived from a pool of 3 mice). TCRab CD4, TCRab
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for iIELs in TNBS-induced colitis has been shown by Inagaki-Ohara
et al. [38], who demonstrated that cd T cell-deficient (Cd2/2) mice
show high susceptibility to TNBS-induced colitis at young age, and
that subsequent transfer of cd IELs to Cd2/2 mice ameliorates
TNBS-induced colitis. Roselli et al. [39] corroborated this result by
illustrating that a probiotic-induced increase in cd-positive iIELs
suppresses TNBS-induced colitis development in treated mice. Most
recently, Jiang et al. [40] were able to show that adoptive transfer of
iIELs to NOD22/2 mice, harboring a strongly reduced number of
iIELs, significantly reduced the susceptibility to TNBS-induced
colitis. Together, these reports suggest an important role for iIELs in
the regulation and prevention of ulcerative colitis.
Alongside, NK receptor expression has been implicated in
colitis development. Hall et al. [34] showed that NKG2A
expression on NK cells protected mice from DSS-induced colitis
development, where NK cells downregulated reactive oxygen
species and cytokine production by activated neutrophils through
direct cell-to-cell contact involving the NK cell inhibitory receptor
NKG2A. Additional data from human studies supports a possible
role of NK receptor expression in ulcerative colitis development
and progression. In this context, the frequency of KIR2DL1 and
KIR2DL3 genotypes was shown to be lower in ulcerative colitis
patients as compared to control individuals [41–43]. Moreover, it
was shown that KIR2DL1/HLA-C2 interaction negatively
correlates with IBD development [44]. Inversely, KIR2DL2 and
KIR2DS2 expression was linked to an increased incidence of
ulcerative colitis [45]. Interestingly, several studies have suggested
KIR receptors to be the human equivalent of Ly49 receptors in
mice [46–48]. Taken together, these studies illustrate that NK
receptor expression on colonic NK cells and some T cell subsets
may influence the course of colitis development. However, to our
CD8ab and TCRab CD8aa iIEL subpopulation frequencies are shown as a percentage of the total TCRab iIELs. TCRcd DN and TCRcd CD8aa iIEL
subpopulation frequencies are shown as a percentage of the total TCRcd iIEL. B) Colon iIEL NK receptor and activation marker expression on TCRab
CD8aa iIELs and TCRcd CD8aa iIELs (mean6SD; n = 5 on day 0, n = 3 on day 7 and n= 4 on day 11, where each value represents the mean of a pool of
3 mice). C) Colon iIEL NK receptor expression on TCRab CD8aa iIELs and TCRcd CD8aa iIELs on day 7 following induction of DSS-induced colitis.
Numbers indicate the percentage of cells expressing the indicated Ly49 receptors, and are each representative of 5 mice. Representative data are
shown on the left. Mean fluorence intensity (MFI) values for each receptor are shown on the right.
doi:10.1371/journal.pone.0110015.g004
Figure 5. iIEL NKG2D expression upon DSS-induced colitis in Ly49E WT and Ly49E KO mice. Colitis was induced in Ly49E WT and Ly49E
KO littermate mice by administration of DSS in drinking water for 7 days. A) NKG2D expression on TCRab CD8aa iIELs. B) NKG2D expression on TCRcd
CD8aa iIELs. N = 2 for control mice, n = 3 for DSS-treated mice.
doi:10.1371/journal.pone.0110015.g005
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knowledge, a role for NK receptor expression on iIELs, in the
context of ulcerative colitis, had not previously been investigated.
Recently, our group demonstrated that expression of inhibitory
Ly49 receptors on iIELs promotes hyporesponsiveness of these
cells [24], and that in vitro TCR-triggering results in upregulation
of Ly49E receptor expression on iIELs, indicating a negative
feedback loop [25]. Thus, we hypothesized that Ly49E expression
on colonic CD8aa-expressing iIELs might provide a new
mechanism through which iIEL function can be regulated in
colitis development and progression. Here, we show that Ly49E
expression on colonic CD8aa-expressing iIELs does not influence
the development or progression of DSS-induced colitis and TNBS-
induced colitis. Relative weight progression, disease activity index
scores, and histological scoring of FFPE-embedded colon sections
showed no significant difference in DSS-induced colitis progres-
sion between Ly49E WT and Ly49E KO mice. Furthermore, iIEL
numbers, iIEL subpopulation frequencies and iIEL phenotype
were unaltered throughout DSS-induced colitis progression in
Ly49E WT versus Ly49E KO mice. Similarly, survival rates,
relative weight progression and iIEL kinetics were not statistically
significant in TNBS-induced colitis between Ly49E WT and KO
mice.
A role for iIELs in ileitis, as modeled by the mouse TNFDARE
model, has been reported by Apostolaki et al. [49], who showed
that intestinal inflammation in TNFDARE/WT mice is associated
with a reduced presence of CD8aa-expressing iIELs. As in
ulcerative colitis, human data studies show a negative influence of
KIR2DL2/KIR2DL3 in Crohn’s disease development and a
protective effect for the KIR2DL1/HLA-C2 interaction [41–44].
Here, we crossed Ly49E WT and Ly49E KO mice to
heterozygous TNFDARE/WT mice in two rounds, generating
TNFDARE/WT Ly49EWT/WT and TNFDARE/WT Ly49EKO/KO
offspring for the study of the role of Ly49E expression on iIELs
in ileitis development and progression. Our results show that
TNFDARE/WT Ly49EWT/WT and TNFDARE/WT Ly49EKO/KO
mice display with similar ileitis disease kinetics. Concurrent with
results from Apostolaki et al. [49], we observe a significant
decrease of TCRab CD8aa iIELs in the small intestine of
TNFDARE/WT mice compared to their littermate controls.
Alongside, we note a significant increase of TCRab CD4 iIELs
in TNFDARE/WT mice compared to their littermate controls.
Furthermore, we show activation of TNFDARE/WT small intestinal
iIELs in ileitis, with significantly higher CD69 expression in
TNFDARE/WT mice as compared to littermate controls. However,
we observe no significant differences in iIEL numbers, subpopu-
lation frequencies, NK receptor expression or activation marker
expression between TNFDARE/WT Ly49EWT/WT and TNFDARE/
WT Ly49EKO/KO mice, illustrating that Ly49E expression on small
intestinal CD8aa-expressing iIELs does not influence ileitis
development or progression.
Conclusively, we report that Ly49E expression is abundant on
iIELs of the small intestine and colon. In this, Ly49E is expressed
on a high proportion of CD8aa-expressing iIELs. However,
Figure 6. TNBS-induced colitis in Ly49E WT versus Ly49E KO mice. Colitis was induced in Ly49E WT and Ly49E KO mice by intra-rectal
administration of TNBS. Mice were analysed at the indicated days. A) Survival (n = 16). B) Relative weight loss (mean 6SD; n = 16). The reference
weight was taken as the weight on day 0, at the start of the experiment. C) Colon histological score (mean 6SD; n= 5). D) Representative
hematoxylin/eosin- stained paraffin sections of the distal colon.
doi:10.1371/journal.pone.0110015.g006
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Ly49E expression on CD8aa-expressing iIELs does not influence
the development or progression of inflammatory bowel diseases.
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